Medical & Scientific Advisors
AЯRE is incredibly fortunate to have medical doctors and scientific advisors who are passionate about helping ASXL affected families. These advisors lead the ASXL registry, are subject matter experts on ASXL syndromes/research, and review/recommend potential research proposals.
Dr. Bianca Russell
Dr. Bianca Russell received her bachelors degree from Connecticut College in New London, Connecticut in 2008 and her medical degree from the University of California, Irvine in 2013. She completed her residency in Pediatrics and Human Genetics at the Cincinnati Children's Hospital in Cincinnati, Ohio and will be a Genetics attending at UCLA beginning in June of 2018. She has focused her career and research on clinical genetics with a particular interest in the management of genetic conditions including Bohring-Opitz Syndrome.
Dr. Wen-Hann Tan
Dr. Wen-Hann Tan a clinical geneticist at Boston Children's Hospital with an interest in diagnosis and management of rare genetic syndromes, including pediatric cancer predisposition syndromes, vascular malformations, and other unusual clinical findings. He has also been actively involved in a longitudinal natural history study and various clinical trials in Angelman syndrome, which is a rare neurodevelopmental disorder.
Dr. Feng-Chun Yang
Dr. Yang is an established investigator in the field of stem cell biology and myeloid malignancies. She is a Professor of Biochemistry and Molecular Biology at the University of Miami, where her area of research is in molecular mechanisms involved in Genetic Disease and Cancer. Dr. Yang has been studying the cellular and molecular mechanisms underlying the pathogenesis of BOS and myeloid malignancies. The ultimate goal of her research is to identify novel therapeutic targets and to develop rational therapies to treat myeloid malignancies and BOS. She has authored over 90 peer-reviewed papers in the field of research and is a member of several professional societies. Dr. Yang also serves on the review boards for numerous professional journals and funding agencies.
Dr. Omar Abdel-Wahab
Dr. Omar Abdel-Wahab is a hematologist/oncologist and Assistant Attending Physician on the Leukemia Service at Memorial Sloan-Kettering Cancer Center. His laboratory focuses on the functional understanding of genetic alterations in patients with chronic myeloid and lymphoid leukemias. One of his main areas of interest is in understanding the role of mutations in the ASXL1 gene and other ASXL family members in cancer and developmental disorders such as Bohring-Opitz Syndrome. His work is currently funded by the Leukemia & Lymphoma Society, the American Society of Hematology, the Evans Foundation for MDS Research, the Damon Runyon Foundation, the V Foundation, the Histiocytosis Foundation, the Hairy Cell Leukemia Foundation, the Erdheim-Chester Disease Global Alliance, and the National Institute of Health.